NCT04001361 is a NA clinical trial of Laser Cell Therapy in Knee Osteoarthritis, sponsored by Endocellutions.

Who is sponsoring NCT04001361?

NCT04001361 is sponsored by Endocellutions.

What drugs are being tested in NCT04001361?

Interventions in NCT04001361: Laser Cell Therapy.

What condition does NCT04001361 study?

NCT04001361 studies Knee Osteoarthritis.

Is NCT04001361 still recruiting?

NCT04001361 is currently status unknown. Last updated 28 June 2019.

Last reviewed 2019-06-28 · How we verify

NCT04001361

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Cell Therapy for Knee Cartilage Repair

Status unknown NA Last updated 28 June 2019

What this trial tests

NA trial testing Laser Cell Therapy in Knee Osteoarthritis in 45 participants. Status unknown.

Timeline

15 July 2019

Primary endpoint
31 December 2019

31 December 2020

Quick facts

Lead sponsor	Endocellutions
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	45
Start date	15 July 2019
Primary completion	31 December 2019
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

Laser Cell Therapy

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Endocellutions

Who can join

18 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laser pulsed energy will be delivered over an optical fiber to create channels into damaged cartilage of the knee or knees. The channels have a diameter of approximately 100 microns or less and an approximate depth of 1 millimeter or less. Bone marrow aspirate will then be delivered into the damaged joint.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04001361 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Endocellutions
Last refreshed: 28 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing